 Growth factors represent an area of interest for surgeons attempting to modify and enhance the wound healing process and tissue regeneration. However, the Platelet-Rich Plasma PRP is already in use for some time by hematologists for transfusions and prevention of bleeding episodes in patients with severe thrombocytopenia. 